Kidney Care Community News

A speculated alternative to the Kidney Allocation System is continuous kidney allocation, which can be designed by simulation optimization, according to a speaker at ASN Kidney Week.

Below is a listing of some new products and product updates released to the renal community in 2021.

The American Kidney Fund has provided more than $150,000 in emergency grants to low-income dialysis and kidney transplant patients affected by Hurricane Ida, the organization said in a press release.

Fresenius Medical Care North America announced the appointments of three individuals to clinical leadership positions.

Research from Kaiser Permanente supports the use of cystatin C tests as an alternative to creatinine-based tests for accurately assessing kidney function without the inclusion of race.

The CMS Molecular Diagnostics Program has issued a local coverage determination for use of a needle-free urine test by NephroSant that detects allograft rejection after kidney transplantation, according to a company press release.

Strive Health has partnered with Nephrology Associates of Northern Illinois and Northern Indiana – an independent nephrology group that has made an equity investment in the company – to pursue and manage global risk payment models.

A joint task force of the National Kidney Foundation and the American Society of Nephrology has released its final report on considering race in diagnosing kidney disease and called for immediate adoption of race-free eGFR equations.

Fresenius Kidney Care’s new dialysis nurse residency program for graduate nurses, called the “first of its kind in dialysis” in a company press release, has supported more than 175 recent graduates.

Following studies showing the benefits of finerenone for patients with chronic kidney disease and type 2 diabetes, Bayer announced it will now investigate the efficacy of the drug for delaying CKD progression in patients without diabetes.